Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets 2017-2022

News provided by

Oct 10, 2017, 17:00 ET

DUBLIN, October 10, 2017 /PRNewswire/ --

The "Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets" report has been added to Research and Markets' offering.

The Global Liquid Biopsy Market Should Reach $4.5 Billion by 2022 from $1.5 Billion in 2017 at a CAGR of 24.2%

Report Includes

An overview of the global markets for liquid biopsy research tools, services, and diagnostics
Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
Coverage of how these technologies can reduce invasive tumor biopsies, drive early cancer detection, and support precise drug administration
Detailed analysis of liquid biopsy workflow technologies, biomarker classes, sample types, and research tools reagents
Breakdowns of the market by product, product type, application, end use industry, technology, and indication
Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities
Profiles of major players in the industry

The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies.The market sizes for liquid biopsy diagnostics are given for the years 2015, 2016, 2017 (estimated) and 2022 (forecasted).

This report reviews liquid biopsy biomarkers and technologies and provides background on why liquid biopsy is increasingly viewed as a replacement for, or a companion to, tissue biopsy.It then discusses several of the significant large-scale research initiatives that are contributing to liquid biopsy development.Market driving forces are also discussed.

The structure of several important industry subsectors is reviewed, as well as major industry acquisitions and strategic alliances from January 2016 through July 2017.Industry subsectors analyzed include next-generation sequencing(NGS) instruments, droplet digital PCR, target enrichment and amplification, single-cell DNA polymerase, prenatal screening, liquid biopsy, direct to consumer, and clinical laboratory.

The market for liquid biopsy diagnostics is analyzed in depth.The market is analyzed by application (cancer, reproductive health, transplant), biomarker type (nucleic acids, cells, extracellular vesicles, proteins), analysis platform (microarray, NGS, PCR, proteomics and other), analysis purpose (screening/early detection, diagnosis, therapy guidance, monitoring) and geography.

Key Topics Covered:

1: Introduction

2: Summary and Highlights

3: Overview

Introduction
Report Scope
Liquid Biopsy versus Traditional Biopsy
Markets
Growth Driving Forces
Key Trends
Industry

4: Technology Background

Liquid Biopsy Biomarkers
Cancer Genomics
Noninvasive Prenatal Testing
Circulating Tumor Cell Technologies
CTC Workflow
Cell Isolation Technologies
CTC Sample Preparation Technologies
CTC Downstream Analysis Technologies
Comparison of Liquid Biopsy with Conventional Biopsy

5: Liquid Biopsy Initiatives

Blood Profiling Atlas
Cambridge Single Cell Analysis Core Facility
Cancer-ID
CTCTrap Consortium
Early Cancer Detection Consortium
Hematologic Oncology Consortium
National Center for Single-Cell Biology
Precancer Genome Atlas
Precision Medicine Initiative
Single Cell Analysis Program
TopMed
Worldwide Innovative Networking (WIN) Consortium

6: Liquid Biopsy Applications

Cancer Applications
Reproductive Health Applications
Transplant Diagnostics Applications

7: Liquid Biopsy Industry

NGS Instrument Industry
Third-Generation Sequencing Industry
Droplet Digital PCR Industry
Target Enrichment and Amplification Industry
Single-Cell DNA Polymerase Industry
NGS Clinical Informatics Industry
Testing Services Industry
Noninvasive Prenatal Testing Industry
Fetal Cell NIPT Industry
CTC Capture and Detection Industry
Liquid Biopsy Industry
Direct-to-Consumer Genetic Testing Industry

8: Acquisitions and Strategic Alliances

Acquisitions
Strategic Alliances

9: Liquid Biopsy Markets

Growth Driving Forces
Liquid Biopsy Market by Indication
Liquid Biopsy Market by Biomarker Type
Liquid Biopsy Market by Analysis Platform
Liquid Biopsy Market by Analysis Purpose
Noninvasive Prenatal Testing Market
Cancer Markets
Transplant Markets
Geographical Market

10: Patent Review

Circulating Tumor Cell Patents
Liquid Biopsy- and Sequencing-Related Patent Issues

11: Company Profiles

3D Signatures
Adaptive Biotechnologies Inc.
Agilent Technologies Inc.
Alcediag
Ambry Genetics
Angle Plc
Apocell Inc.
Appistry Inc.
Arup Laboratories
Asuragen Inc.
Atreca Inc.
Aviva Biosciences
Baylor Miraca Genetics Laboratories Inc.
Becton, Dickinson And Co.
Bellwether Bio Inc.
Berry Genomics Co. Ltd.
Bgi Shenzhen
Biocartis Nv
Biocept Inc.
Biodesix Inc.
Biofluidica Inc.
Biogazelle
Biomarx Inc.
Bio-Rad Laboratories Inc.
Bio-Techne Ltd.
Biovendor-Laboratorni Medicina A.S.
Boreal Genomics
Cancer Genetics
Cegat Gmbh
Cellmax Life
Cell Microsystems Inc.
Cellular Research Inc.
Celsee Diagnostics
Chronix Biomedical
Circulogene Theranostics
Circulomics Inc.
Cirina
Clinomics Co. Ltd.
Codiak Biosciences
Color Genomics
Cooper Surgical Inc.
Coriell Life Sciences Inc.
Cynvenio Biosystems Inc.
Cypher Genomics Inc.
Cytotrack Aps
Danaher Corp.
Diacarta Inc.
Diagnologix, Llc
Diagnomics
Diploid
Dna Electronics Ltd.
Dnalytics
Dnanexus Inc.
Edico Genome
Envision Genomics
Epic Sciences
Eurofins Genomics
Exact Sciences Corporation
Exosome Diagnostics Inc.
Fabric Genomics, Inc.
Foundation Medicine Inc.
Fluxion Biosciences Inc.
Freenome Inc.
Gatc Biotech Ag
Genapsys Inc.
Genedx Inc.
Genomatix Software Gmbh
Genomic Health Inc.
Genomoncology
Genospace
Gigagen Inc.
Good Start Genetics Inc.
Golden Helix
Grail
Guardant Health Inc.
Helitec
Helix Opco Llc
HTG Molecular Diagnostics Inc.
Human Longevity Inc.
Illumina Inc.
Inex Innovations Exchange Pte Ltd.
Inivata Ltd.
Interpace Diagnostics Llc
Invitae
Invivoscribe Inc.
Irepertoire Inc.
Kellbenx Inc.
Laboratory Corporation Of America Inc.
Mdna Life Sciences Inc.
Maverix Biomics Inc.
MDX Health Inc.
Medgenome Labs Pvt. Ltd.
Menarini Silicon Biosystems
Merck Kgaa
Molecular Health Gmbh
Myriad Genetics Inc.
Namocell Inc.
Nanostring Technologies Inc.
Natera Inc.
Neogenomics Inc.
New England Biolabs
New Oncology Gmbh
Nipd Genetics
N-Of-One Inc.
Novogene Corporation
Nugen Technologies Inc.
NX Prenatal Inc.
Oncocyte Corporation
Oncodna Sa
Oxford Nanopore Technologies Ltd.
Pacific Biosciences Of California Inc.
Pangaea Oncology
Paradigm Diagnostics Inc.
Parseq Lab S.R.O.
Pathway Genomics Corporation
Personal Genome Diagnostics Inc.
Pieriandx
Population Genetics Technologies Ltd.
Portable Genomics Llc
Predicine Inc.
Premaitha Health Plc
Prenetics
Provista Diagnostics Inc.
Qiagen Nv
Quantapore Inc.
Quantum Biosystems Inc.
Quantumdx
Quest Diagnostics Inc.
Rarecells Sas
Rarecyte Inc.
Real Time Genomics Inc.
Resolution Bioscience Inc.
Roche Holding Ag
Screencell
Sengenics International Pte Ltd.
Sequencing.Com
Seven Bridges Genomics Inc.
Singlera Genomics
Sophia Genetics
Spera Medical
Sphere Fluidics Limited
Station X Inc.
Stilla Technologies
Strand Life Sciences Pvt. Ltd.
Stratec Biomedical Ag
Stratos Genomics Inc.
Syapse
Sygnis Ag
Sysmex Inostics Gmbh
TAI Diagnostics Inc.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Thorne Diagnostics Inc.
Trovagene Inc.
Transgenomic Inc.
Twinstrand Biosciences
Two Pore Guys Inc.
Ubiquity Genomics Inc.
Vela Diagnostics
Volitionrx
Xcell Biosciences Inc.
Yikon Genomics Co. Ltd.
ZS Genetics Inc.

For more information about this report visit https://www.researchandmarkets.com/research/tsv2dq/liquid_biopsy

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets